• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Acceleron Pharma Inc - Articles and news items

luspatercept-blood

FDA Fast Track designation granted to luspatercept for the treatment of patients with beta-thalassemia

Industry news / 18 May 2015 / Victoria White

The FDA has granted Fast Track designations to luspatercept for two separate indications for the treatment of patients with beta-thalassemia…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +